Valuation: Brooks Laboratories Limited

Market Cap 1.81B 18.89M 16.47M 15.55M 14.12M 26.46M 26.57M 186M 71.89M 922M 70.96M 69.38M 2.97B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.83B 19.08M 16.64M 15.71M 14.27M 26.73M 26.84M 188M 72.62M 931M 71.68M 70.09M 3B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
44.12%
Yield 2025 *
-
Yield 2026 -
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-19 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-07 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
29/05/25 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/02/25 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
26/12/24 Brooks Laboratories Limited Appoints Ms. Krutika Mohan Rane as Company Secretary & Compliance Officer, Effective 26 December 2024 CI
1 day-1.35%
1 week-3.43%
Current month-8.10%
1 month+1.05%
3 months-8.65%
6 months+10.22%
Current year-23.50%
1 week 58.77
Extreme 58.77
65.55
1 month 58.77
Extreme 58.77
71.35
Current year 36.9
Extreme 36.9
82.3
1 year 36.9
Extreme 36.9
153.65
3 years 36.9
Extreme 36.9
202.8
5 years 36.9
Extreme 36.9
202.8
10 years 14.05
Extreme 14.05
202.8
Manager TitleAgeSince
Chief Executive Officer 58 23/01/2002
Chief Executive Officer - 01/06/2026
President 57 23/08/2023
Director TitleAgeSince
Director/Board Member 53 23/11/2022
Director/Board Member 62 10/09/2010
Director/Board Member - 23/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-3.43% - - 18.83M
-1.61%-1.27%+13.40%+59.79% 46.78B
-1.02%-3.01%+36.66%+100.50% 37.88B
+2.19%+3.78%+12.21%+79.75% 11.82B
+1.32%+1.54%-10.59%+12.87% 11.61B
-0.95%-0.38%+17.65%+146.45% 9.12B
+0.39%+2.72%+29.99%+39.46% 7.38B
+1.30%+1.34%+19.83%+185.74% 7.12B
-0.06%+1.94%+39.71%-18.67% 7.21B
+0.70%-2.06%-42.22%+7.42% 4.99B
Average +0.09%+0.45%+12.96%+68.15% 15.99B
Weighted average by Cap. -0.46%-0.09%+18.32%+73.30%

Financials

2025 2026
Net sales 826M 8.6M 7.5M 7.08M 6.43M 12.05M 12.1M 84.86M 32.75M 420M 32.32M 31.6M 1.35B 857M 8.94M 7.79M 7.36M 6.68M 12.52M 12.57M 88.13M 34.01M 436M 33.57M 32.82M 1.4B
Net income -99.67M -1.04M -906K -855K -777K -1.46M -1.46M -10.24M -3.95M -50.67M -3.9M -3.82M -163M 246M 2.56M 2.23M 2.11M 1.92M 3.59M 3.6M 25.27M 9.75M 125M 9.62M 9.41M 402M
Net Debt 75.39M 786K 685K 647K 587K 1.1M 1.11M 7.75M 2.99M 38.33M 2.95M 2.89M 123M 18.44M 192K 168K 158K 144K 269K 270K 1.9M 731K 9.37M 722K 706K 30.16M
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
18/09/26 61.39 -1.35% 16,612
17/09/26 ₹62.23 +1.70% 3,818
16/09/26 ₹61.19 -4.44% 2,454
15/09/26 ₹64.03 -3.35% 4,128
11/09/26 ₹66.25 +4.22% 6,842
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!